CorMedix (CRMD) Tops Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Join SI Premium – FREE
CorMedix (NASDAQ: CRMD) reported Q1 EPS of $0.32, $0.16 better than the analyst estimate of $0.16. Revenue for the quarter came in at $39.1 million versus the consensus estimate of $32.35 million.
For earnings history and earnings-related data on CorMedix (CRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
- L3Harris CEO steps down amid conduct review, shares drop
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
